Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...
Bladder cancer is one of the most common cancers worldwide. Men are around four times more likely to develop it than women, ...
Cystoscopy without the aid of urinary markers is the most cost-effective strategy for detecting recurrence of non-invasive bladder cancer, according to researchers. In a study that examined five ...
This was a single-center, retrospective analysis of 42 patients with MIBC who underwent TMT at the Moffitt Cancer Center ...
As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that 14 studies ...
In a recent conversation with CURE, Hensley discussed the current treatment landscape of non-muscle-invasive bladder cancer, as well as how patient counseling is guided by individual risk factors.